Catalent Inc (NYSE:CTLT)
| 102.09 Delayed Data As of Jan 21 |  +0.07 / +0.07%Today’s Change | 97.86 Today|||52-Week Range 142.64 | -20.26% Year-to-Date |
Latest CTLT News | Press Releases
Today’s Trading
| Previous close | 102.02 |
| Today’s open | 102.18 |
| Day’s range | 100.76 - 103.37 |
| Volume | 1,174,827 |
| Average volume (3 months) | 1,028,649 |
| Market cap | $18.5B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +172.65% |
| Earnings growth (this year) | +22.05% |
| Earnings growth (next 5 years) | +14.42% |
| Revenue growth (last year) | +29.21% |
| P/E ratio | 32.0 |
| Price/Sales | 4.60 |
| Price/Book | 4.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VTRSViatris Inc | -0.11 | -0.75% |
| INCYIncyte Corp | +0.03 | +0.04% |
| ALNYAlnylam Pharmaceutic... | -2.02 | -1.46% |
| HZNPHorizon Therapeutics... | -0.08 | -0.09% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | February 7, 2022 |
| EPS forecast (this quarter) | $0.83 |
| Annual revenue (last year) | $4.0B |
| Annual profit (last year) | $529.0M |
| Net profit margin | 13.23% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Somerset, New Jersey |
Forecasts
